Pharmaxis Ltd ADR (PXSLY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 06/30
| 06-2018 | 06-2017 | 06-2016 | 06-2015 | 06-2014 | |
| Sales | 39,411 | 13,571 | 13,857 | 59,240 | 4,620 |
| Cost of Goods | 1,375 | 1,000 | 1,405 | 1,730 | 1,700 |
| Gross Profit | 38,035 | 12,571 | 12,452 | 48,150 | 2,910 |
| Operating Expenses | 24,386 | 26,482 | 24,653 | 49,220 | 41,330 |
| Operating Income | 14,024 | -12,911 | -11,796 | 9,020 | -37,710 |
| Interest Expense | 437 | 470 | -1,792 | 2,690 | 0 |
| Other Income | -8,611 | -451 | -1,985 | 12,170 | -9,770 |
| Pre-tax Income | 4,977 | -13,831 | -11,989 | 18,500 | -47,480 |
| Income Tax | 6 | N/A | 5 | 40 | 90 |
| Net Income Continuous | 4,971 | -13,831 | -11,994 | 15,462 | -39,514 |
| Net Income | $4,971 | $-13,831 | $-11,994 | $18,460 | $-47,580 |
| EPS Basic Total Ops | 0.23 | -0.60 | -0.57 | 0.75 | -2.31 |
| EPS Basic Continuous Ops | 0.23 | -0.65 | -0.57 | 0.75 | -1.92 |
| EPS Diluted Total Ops | 0.23 | -0.60 | -0.57 | 0.74 | -2.31 |
| EPS Diluted Continuous Ops | 0.23 | -0.65 | -0.57 | 0.74 | -1.92 |
| EPS Diluted Before Non-Recurring Items | 0.23 | -0.66 | -0.57 | 0.74 | N/A |
| EBITDA(a) | $14,024 | $-10,605 | $-9,465 | $12,100 | $-24,940 |